Part of growing Transcriptic means making industry leading protocols and reagents accessible to our users. For this reason I’m happy to announce that on November 4 2016 Agilent Technologies’ QuikChange Lightning, site-directed mutagenesis kit will be available in the Transcriptic protocol browser.
Since the start of Transcriptic users have only been able to conduct Biosafety Level 1 (BSL-1) experiments on our automated cloud infrastructure. We believed that executing well at this lower stringency threshold meant that we could deliver a great service for our users whilst still ensuring we could rapidly develop our capabilities.
We recently hosted the second annual Autoprotocol Summit at our new San Francisco office. With the gorgeous city of San Francisco as a backdrop, we took the day to think about how Autoprotocol has changed since the first Autoprotocol Summit in 2016, and how we can make it even better.
EASIER DEVELOPMENT OF PACKAGES
The Transcriptic CLI tool was recently updated to make protocol package development faster. The new launch command quickly allows you to preview the UI generated by the package as well as the autoprotocol JSON.
SO YOU WANT TO PROGRAM A BIOLOGY LAB? YOU'RE IN THE RIGHT PLACE.
Today we are going to instruct a completely automated robotic cloud lab to grab a genetically modified strain of bacteria from a library of common reagents, innoculate some bacterial growth media and finally watch how that culture grows over 8 hours by seeing how the bacteria scatter 600nm light.
So I’m going to let you in on a little secret... Transcriptic is going to be at SLAS 2016 and we’ve got some amazing things to share with you. SLAS is the Society for Laboratory Automation and Screening, and SLAS2016 is the annual conference perfect for those seeking automated tools to conduct their research, I think we’ll fit in pretty well.
A quick update for all of our wonderful Transcriptic users. We recently added the Bionex HiG microplate centrifuge into to our robotic cloud lab expanding our centrifuge capabilities. The HiG is a great piece of kit and we’re very happy to have it.
Transcriptic has grown fast over the last 8 months. In fact, we've doubled in size since we closed our $9M Series A back in January.
It's amazing how things that worked well back when we were eight people don't work at all now, and how much the feeling of the company has changed over time. This growth meant that we had to start thinking about how to go from engineering a technology to building a company.
Over the last few weeks we’ve made some big changes to our inventory reservation system: most notably the "reserve" button next to each reagent that allowed you to reserve an aliquot and make it available in your inventory has disappeared. In the interest of allowing the reservation of arbitrary amounts of resources instead of pre-designated aliquot sizes, we’ve switched from a system of reserving resources to provisioning them. This way, you only pay for the reagents you use and Transcriptic takes care of making sure reagents are as fresh as possible so you don’t have to. For most users, this transition doesn’t mean much except less work. For protocols where you would have had to choose aliquots of reagents like ligase buffer or polymerase that you had previously reserved from your own inventory, appropriate volumes of those reagents are now automatically provisioned from within the protocol and pricing is rolled into the cost of the run accordingly.
Today I'm excited to announce that we've raised approximately $8.5 million in a Series A financing, bringing the total investment in the company to a little over $14 million. The round was led by Data Collective with participation from IA Ventures, AME Cloud Ventures, Silicon Valley Bank, 500 Startups, MITS Fund, Y Combinator, Paul Buchheit, and a bunch of other angels. The round officially closed at the very end of December, 11 months after we raised a $2.8M "Series Seed" led by IA Ventures.